GHK-Cu (50 mg Vial) Dosage Protocol

GHK-Cu (50 mg Vial) Dosage Protocol

#dosing-schedule .dr-container > header { margin-bottom: 0 !important; padding-bottom: 0 !important; }
#dosing-schedule .dr-container > header * { margin-bottom: 0 !important; }
#dosing-schedule .dr-container > header::before, #dosing-schedule .dr-container > header::after { content: none !important; display: none !important; }
#dosing-schedule .dr-container > section:first-of-type { margin-top: 0 !important; display: flow-root; }
#dosing-schedule .dr-container > section:first-of-type h2:first-child { margin-top: 0 !important; }
#dosing-schedule .dr-container .wp-block-spacer, #dosing-schedule .dr-container hr { display: none !important; height: 0 !important; margin: 0 !important; border: 0 !important; }

Quickstart Highlights

GHK-Cu (copper tripeptide-1) is a naturally occurring copper complex of the tripeptide glycyl-L-histidyl-L-lysine that declines with age and acts as a broad genomic repair signal, stimulating collagen synthesis, balancing matrix metalloproteinases, and suppressing inflammatory gene expression[1][2]. Research-grade GHK-Cu is used as a subcutaneous injectable solution for systemic and local repair applications.

  • Reconstitute: Add 5.0 mL bacteriostatic water → 10.0 mg/mL concentration.
  • Typical daily dose: 1–2 mg once daily (subcutaneous).
  • Easy measuring: At 10.0 mg/mL, 1 unit = 0.01 mL ≈ 100 mcg on a U-100 insulin syringe.
  • Storage: Lyophilized: freeze at −20 °C (−4 °F); after reconstitution, refrigerate at 2–8 °C (35.6–46.4 °F); use within 4 weeks.
GHK-Cu 50mg Vial

Dosing & Reconstitution Guide

Educational guide for reconstitution and daily dosing

Standard Daily Protocol (5.0 mL = 10.0 mg/mL)

Week(s) Daily Dose (mcg / mg) Units (per injection) (mL)
Weeks 1–2 (starting dose) 1,000 mcg (1 mg) 10 units (0.10 mL)
Weeks 3–4 (standard dose) 2,000 mcg (2 mg) 20 units (0.20 mL)

Frequency: Inject once daily subcutaneously. Begin at the lower 1 mg dose for the first 1–2 weeks to assess tolerability, then advance to 2 mg daily if no adverse reactions are observed[3]. At 10.0 mg/mL, the 50 mg vial provides 25 days at 2 mg/day or a 50-day supply at 1 mg/day.

Reconstitution Steps

  1. Allow frozen vial to warm to room temperature (10–15 minutes).
  2. Draw 5.0 mL bacteriostatic water with a sterile syringe.
  3. Inject slowly down the vial wall to minimize foaming. Do not inject directly onto the lyophilized cake.
  4. Gently swirl or roll until fully dissolved—do not shake vigorously. Note: GHK-Cu solution will appear blue due to the copper chelation; this is normal.
  5. Label with reconstitution date and peptide name. Refrigerate at 2–8 °C, protected from light.
  6. Use within 4 weeks of reconstitution for optimal potency.

Important: This guide is for educational purposes only and is not medical advice. For research use only. Not for human consumption.

Supplies Needed

Plan based on a 4-week daily protocol at 2 mg/day (2,000 mcg).

  • GHK-Cu Vials (50 mg each):
    • 4 weeks at 2 mg/day (28 days): needs 56 mg → 2 vials
    • 4 weeks at 1 mg/day: 1 vial
  • Insulin Syringes (U-100, 0.3 mL / 30-unit preferred):
    • 4 weeks: 28 syringes (one per day)
  • Bacteriostatic Water (10 mL bottles):
    • Per vial: 5.0 mL → 1 × 10 mL bottle per vial
  • Alcohol Swabs: 2 per day (one for vial stopper, one for injection site) → 56 swabs per 4-week cycle.
GHK-Cu 50mg
View Supplier
Insulin Syringes
View Supplier
Bacteriostatic Water
View Supplier
Alcohol Pads
View Supplier

Protocol Overview

  • Goal: Support skin repair, wound healing, and matrix remodeling through collagen synthesis stimulation, MMP/TIMP balance, and broad genomic anti-inflammatory signaling[1][2].
  • Schedule: Daily subcutaneous injections for 4 weeks, followed by a 2–4 week rest period.
  • Dose range: 1–2 mg once daily; begin low and titrate up as tolerated.
  • Reconstitution: 5.0 mL per 50 mg vial (10.0 mg/mL).
  • Storage: Lyophilized frozen at −20 °C; reconstituted refrigerated at 2–8 °C; use within 4 weeks.

Dosing Protocol

  • Starting dose: 1,000 mcg (10 units / 0.10 mL) once daily for Weeks 1–2[3].
  • Standard dose: 2,000 mcg (20 units / 0.20 mL) once daily for Weeks 3–4.
  • Frequency: Once daily, subcutaneous.
  • Cycle length: 4-week active cycle; 2–4 weeks off before reassessment.
  • Volume: 0.10–0.20 mL well within subcutaneous comfort range[6].

Storage Instructions

  • Lyophilized: Store at −20 °C (−4 °F) or below for long-term stability[5]. Protect from moisture and light.
  • Reconstituted: Refrigerate at 2–8 °C (35.6–46.4 °F). Do not freeze. Use within 4 weeks.
  • Color check: GHK-Cu solutions appear blue—this is normal and indicates intact copper chelation.
  • Inspect solution before each use; discard if discolored beyond the expected blue, cloudy, or particulate.

Important Notes

  • Use new sterile insulin syringes for each injection; dispose in a sharps container immediately.
  • Rotate injection sites (abdomen, thighs, upper arms) at least 1–2 inches apart to prevent local irritation.
  • GHK-Cu solution is normally blue; inspect clarity but do not expect the colorless appearance of other peptides.
  • Document daily dose, injection site, and any skin or local reactions to track response.

How This Works

GHK-Cu is a copper(II) complex of the tripeptide glycyl-L-histidyl-L-lysine that naturally occurs in human plasma, saliva, and urine. First isolated by Loren Pickart in 1973, plasma concentrations peak at approximately 200 ng/mL in young adults and fall to ~80 ng/mL by age 60[1].

Systemically administered GHK-Cu acts on multiple repair pathways. It stimulates fibroblasts to produce collagen I, III, and IV as well as glycosaminoglycans including dermatan and chondroitin sulfate[2]. It modulates the balance of matrix metalloproteinases (MMPs) and their tissue inhibitors (TIMPs), enabling healthy matrix remodeling without excessive scar formation. It upregulates decorin, a small proteoglycan that organizes collagen fibrils for improved mechanical strength[2]. At the gene expression level, GHK-Cu can shift over 4,000 human genes toward repair and away from inflammatory destruction, including 31 genes associated with COPD-like tissue damage[1]. It also delivers bioavailable copper to cuproenzymes including lysyl oxidase (critical for collagen and elastin cross-linking) and SOD1 (antioxidant defense).

Potential Benefits & Considerations

  • Skin rejuvenation: Human cosmetic trials show improved texture, fine-line reduction, and collagen density with topical GHK-Cu; injectable research extends these benefits systemically[3].
  • Wound healing: Multicenter RCT demonstrated accelerated closure of diabetic foot ulcers with GHK-Cu gel adjunctive therapy[3].
  • Post-procedure support: Randomized split-face trial showed improved CO2-laser resurfacing recovery with topical copper tripeptide complex[4].
  • Tolerability: Generally well tolerated in cosmetic and clinical studies; systemic copper toxicity is unlikely at typical research doses given the high-affinity chelation that prevents free copper reactivity.
  • Blue color: The characteristic blue appearance of GHK-Cu solutions can concern new users but is normal and expected.

Lifestyle Factors

  • Maintain adequate dietary protein (1.2–1.6 g/kg body weight) to provide amino acids for collagen synthesis.
  • Ensure adequate vitamin C intake (collagen cross-linking cofactor) and dietary zinc (wound healing cofactor).
  • Protect skin from UV exposure during GHK-Cu protocols—new matrix is photosensitive.
  • Adequate hydration supports dermal hydration and glycosaminoglycan production.

Injection Technique

  • Clean vial stopper and injection site with separate alcohol swabs; allow both to air-dry fully.
  • Using a 29–31 gauge insulin syringe (5/16″ to 1/2″ needle), draw the calculated dose.
  • Pinch a skin fold; insert needle at 45° into subcutaneous tissue (90° acceptable with short needles into a pinched fold)[6].
  • Inject slowly over 2–3 seconds; do not aspirate. Withdraw and apply gentle pressure.
  • Rotate sites; dispose of syringe in sharps container immediately.

Important Note

This content is intended for educational purposes only and does not constitute medical advice, diagnosis, or treatment. GHK-Cu is not approved for human therapeutic use as an injectable. For research use only.

References


  • International Journal of Molecular Sciences (MDPI, 2018)
    — Regenerative and Protective Actions of the GHK-Cu Peptide in the Light of New Gene Data
    View Source

  • PubMed — Simeon & Maquart (1999)
    — Modulation by GHK-Cu of collagen synthesis and MMP/TIMP expression in dermal fibroblasts
    View Source

  • Wound Repair and Regeneration — Mulder et al. (1994)
    — Enhanced healing of diabetic foot ulcers with GHK-Cu gel adjunctive therapy (multicenter RCT)
    View Source

  • Archives of Facial Plastic Surgery — Miller et al. (2006)
    — Effects of topical copper tripeptide complex on CO2 laser resurfacing recovery (randomized split-face trial)
    View Source

  • Bachem Peptide Technical Guide
    — Handling and Storage Guidelines for Peptides (lyophilized and reconstituted forms)
    View Source

  • CDC — General Best Practice Guidelines for Immunization
    — Subcutaneous injection technique, angle, and site rotation guidance
    View Source